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Background: Analgesia is often indicated in rabbits undergoing surgical procedures or suffering from various
painful conditions and the most common adverse effects associated with NSAIDs occur in the gastrointestinal
tract (GIT). The objective of this study was to determine the potential effect of long-term (21 days) meloxicam
administration on the fecal bacterial microbiota in healthy rabbits.
Samples of hard feces were collected from six rabbits treated with meloxicam (1 mg/kg orally once every 24 h) on
days 0,6,14 and 21. Next generation sequencing of V4 16S rRNA gene products was performed.
Results: A total of 2589912 V4 rRNA gene sequences passed all quality control filters. Firmicutes predominated
(82.0 ± 6.2%). Sixteen other phyla were also identified but other than Verrucomicrobia (4.4 ± 4.9%), all accounted for
less than 1% of the identified sequences. Within Firmicutes, Clostridia was the dominant class, accounting for 76%
of operational taxon units (OTUs). In general, there were only few differences observed between time points and
different rabbits at the phylum level. A significant change was observed in the relative abundance of Proteobacteria
over the 4 time points (P = 0.02).
Conclusions: The gastrointestinal tract of rabbits harbors dense and diverse microbiota. Significant alteration of the
hard fecal microbiota does not appear to be a considerable adverse effect expected in rabbits treated for 21 days
with oral meloxicam at a dose of 1 mg/kg.
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Analgesia is a basic aspect of veterinary medicine, indi-
cated in both laboratory and pet-owned animals under-
going surgical procedures or suffering from various
painful conditions [1]. One of the most common classes
of drugs used by veterinarians for analgesia is non-
steroidal anti-inflammatory drugs (NSAIDs) [1]. Nonste-
roidal anti-inflammatory drugs reduce inflammation by
inhibiting the action of Cyclooxygenase (COX) enzymes,
which convert arachidonic acid into prostanoids and an-
algesia associated with NSAIDs is mainly due to inhib-
ition of COX-2 [2]. The most common adverse effects
associated with NSAIDs occur in the gastrointestinal
tract (GIT), and to a lesser degree, impairment of renal* Correspondence: jsweese@uoguelph.ca
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article, unless otherwise stated.blood flow [3,4]. Reported NSAIDs-related GIT patholo-
gies include perforation, ulceration, bleeding and local
irritation [3,4]. Because prostaglandins also play a role in
the rabbit’s GIT motility [5], NSAIDs have the potential
to also impair GIT function. To date, several studies
have been performed to determine pharmacokinetics
and safety of meloxicam in rabbits but none had looked
into the potential drug’s effect on GIT microbiota [6-8].
The fecal or intestinal microbiota of domestic rabbits
has been extensively studied through culture dependent
methods, as well as earlier generation culture-independent
methods, with a focus on the cecal microbiota [9-13].
However, limitations of these methods for understanding
the overall microbial composition are well known. In par-
ticular, culture-dependent studies are only able to provide
a very superficial (and sometimes misleading) assessment
of this complex polymicrobial environment [14-16]. While
earlier studies have provided some important information,ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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such as this to evaluate millions of bacterial sequences
from diverse (and often unculturable) microbial popula-
tions is now possible.
This study explores the stability over time of bacterial
communities in hard feces in healthy rabbits medicated
with oral meloxicam, using high throughput sequencing
of the V4 region of the 16S rRNA gene.
Methods
Study population
Ethical approval was obtained from the Institutional
Animal Care and Use Committee of Kansas State Uni-
versity. Rabbits enrolled in this study were part of a
broader study evaluating long term (29 days) administra-
tion of oral meloxicam. Six clinically normal 3-month-
old intact female New Zealand White rabbits (body
weight range, 2.52 to 2.71 kg) were included in this
study. The rabbits were obtained from a commercial
source and were specific pathogen (Pasteurella sp.) free.
The rabbits were housed individually at the research fa-
cilities of the Kansas State University College of Veterinary
Medicine at a constant temperature (21°C) and humid-
ity (60%), and were exposed to cycles of 16 hours of
light and 8 hours of dark per day. Rabbits were fed free
choice of timothy haya, timothy-based pelleted dietb
and water was available ad libitum. Rabbits were accli-
mated to the facility for 5 days after their arrival and
were habituated to handling prior to initiation of the
study. Immediately prior to the start of the study, each
rabbit was determined to be behaviorally normal and
healthy based on a thorough physical examination and
clinical pathology testing (complete blood count [CBC],
serum biochemistry profile and urinalysis), with results
compared to published reference ranges [17]. Physical
examination, weight and blood testing were repeated
weekly in all rabbits enrolled in the study. Fecal pro-
duction was subjectively monitored for shape, color
and consistency, and objectively by weight and fecal
pellet size. At the end of the study, all rabbits were hu-
manely euthanatized using pentobarbitalc (100 mg/kg
Intravenous), and necropsy was performed within 15 mi-
nutes of euthanasia.
Experimental design and sample collection
Meloxicamd (1 mg/kg) was orally administered daily for
29 days to each rabbit via a 3-mL syringe. The rabbits’ be-
haviour, attitude, mentation, level of activity, eating and
drinking, and defecation were subjectively assessed daily by
the researchers. Hard fecal samples were collected prior to
treatment (day 0) and on days 6, 14 and 21 from the start
of the meloxicam treatment. At each time point morning
(08:00), 10 fecal pellets from a fresh elimination were placed
into an individual collection bag. Therefore, four fecalsamples were collected from each rabbit during the study
period for determination of fecal microbiota. Each sample
(10 fecal pellets) was weighed using a digital gram scale and
each fecal pellet was measured using hand calipers. All
bagged samples were stored at −70°C until analysis.
DNA extraction and quality control
DNA extraction was performed using a commercial kite
following the manufacturer’s “stool DNA protocol for
pathogen detection”, which includes an initial bead beat-
ing step and proteinase K treatment. DNA quantity and
quality were accessed by spectrophotometry using the
NanoDropf.
16 s rRNA gene amplification and sequencing
PCR amplification of the V4 region of the 16S rRNA
gene was designed based on Klindworth et al. [18] using
the primers forward S-D-Bact-0564-a-S-15 (5′-AYTGG-
GYDTAAAGNG-3′) and reverse S-D-Bact-0785-b-A-18
(5′-TACNVGGGTATCTAATCC-3′). The forward and
reverse primers were designed containing an overlapping
region of the forward and reverse Illumina sequencing
primers (TCGTCGGCAGCGTCAGATGTGTATAAGA-
GACAG and GTCTCGTGGGCTCGGAGATGTGTA-
TAAGAGACAG, respectively) in order to anneal them
to primers containing the Illumina adaptors plus the
8 bp identifier indices (forward: AATGATACGGCG
ACCACCGAGATCTACAC-index-TCGTCGGCAGCGTC;
reverse: CAAGCAGAAGACGGCATACGAGAT-index-GT
CTCGTGGGCTCGG). For a final volume of 50 μL, 2 μL of
each DNA sample were added to a solution containing
18.7 μL of water, 25 μL of ReadMisg, 1.3 μL of BSAh, 0.5 μL
of each 16S primer (1000 pmol/μL) and 1 μL of each Illu-
mina primer (1000 pmol/μL). The mixture was subjected to
the following PCR conditions, 3 minutes at 94˚C for de-
naturing, and 35 cycles of 45 seconds at 94˚C for denatur-
ing, 60 seconds at 50˚C for annealing and 90 seconds at
72˚C for elongation followed by a final period of 10 minutes
at 72˚C and kept at 4˚C until purification.
PCR products were evaluated by electrophoresis in 2%
agarose gel and purified with the Agencourt AMPure
XPi by mixing 22 μL of amplicon with 72 μL of AMPure
on a 96 well plate. After 5 minutes at room temperature,
beads were separated and washed twice with 80% etha-
nol and eluted in 30 μL of water. After purification sam-
ples were quantified by spectrophotometry using the
NanoDropj and normalized to a final concentration of 2
nM. Sequencing of the library pool was performed at the
University of Guelph’s Advanced Analysis Centre using
an Illumina MiSeqk and 2x250 chemistry.
Microbiome assessment
The MOTHUR package of algorithms (v1.30) was
used for analysis [19]. Paired end reads were aligned.
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calls or long runs (>8 bp) of holopolymers were removed,
as were sequences that did not align with the correct
region. Chimeras were detected using uchime [20] and
removed. Sequences from chloroplasts, mitochondria,
Archaea and eukaryotes were also removed.
Sequences were binned into OTUs at a 3% (0.03) dis-
similarity level, and taxonomy was assigned using the
Silva 16S rRNA reference database [21].
Coverage was assessed using Good’s coverage. Popula-
tion diversity was described using the inverse Simpson’s
index. Relative abundances were compared between ani-
mals and between timepoints using ANOVA.
Dissimilarity between the two groups was assessed
through creation of dendrograms using the Yue & Clayton
measure of dissimilarity (a measure of community struc-
ture, which considers shared OTUs and their relative
abundances) and traditional Jaccard index (a measure of
community membership, which considers the number
of shared OTUs, not their abundance). Parsimony and
unweighted unifrac [22] tests were applied to evaluate
the impact of day of treatment on population structure.
Principal coordinate analysis (PCoA) was also performed,
based on both Jaccard and Yue and Clayton indices. Ana-
lysis of molecular variance (AMOVA), a non-parametric
evaluation of genetic diversity, was used to evaluate the
impact of day.
Results
Meloxicam was easily administered daily to each rabbit,
and all of the rabbits seemed to remain healthy during the
study. Subjectively, none of the rabbits had changes in be-
havior, attitude, mentation, level of activity, amount of food
or water consumed, or fecal production. Objectively, all
participating rabbits continued to gain weight (final body
weight range 2.61-2.91 Kg) when compared to the begin-
ning of the study period. Also, all values in the weekly
serum biochemistry analysis were within normal limits both
before and during the study. No changes were observed in
hard feces’ shape, color and consistency (no diarrhea or
ileus). The mean weight of a 10-pellet fecal sample was
6.75 g (range 6–9 g) and mean measured individual fecal
pellet size was 6.2 mm (range 5–8 mm). Post-study gross
necropsy and histopathologic evaluation of all participating
rabbits did not reveal any major abnormalities.
A total of 3453182 V4 16S RNA gene sequences were
obtained; 2589912 of which passed all quality control fil-
ters. The number of sequences per sample ranged from
35178 to 250720 (mean 107913, SD 42703). Further ana-
lysis was performed on random subsampling of 35178 se-
quences per sample. Excellent sample coverage was
obtained with this subsampled population, as demon-
strated by a mean Good’s coverage value of 0.972 (SD
0.002, range 0.967-0.975) and rarefaction curves (Figure 1).The number of OTUs ranged from 1814–2525 (mean
2118, SD 170). There was no impact of rabbit (P = 0.16) or
day (P = 0.16) on the number of different OTUs that were
identified. The overall mean inverse Simpson’s value was
73.6 (SD 23.6, range 19.5-119), with no impact of day (P =
0.54) or rabbit (P = 0.07).
The microbiota of all rabbits was dominated at the
phylum level by Firmicutes, which accounted for 66.6 ±
6.7% (mean ± SD) of sequences (Figure 2). Sixteen other
phyla were identified; however, only Verrucomicrobia
(4.4 ± 5.1%) and accounted for greater than 1% of se-
quences. These other phyla consisted of Actinobacteria
(0.18 ± 0.13%), Bacteroidetes (0.38 ± 0.26%), Chlamydiae
(0.001 ± 0.00%), Cyanobacteria (0.003 ± 0.003), Deinococcus-
Thermus (0.0001 ± 0.0005%), Fibrobacteres (0.021 ± 0.014%),
Fusobacteria (0.003 ± 0.002%), Lentisphaerae (0.002 ± 0.002%,
Plantomycetes (0.0002 ± 0.0008), Proteobacteria (0.57 ±
0.33%), Spirochaetes (0.043 ± 0.24%), Synergistetes (0.005 ±
0.001%), Tenericutes (0.021 ± 0.017%), SR1 (0.0006 ± 0.001%)
and TM7 (0.06 ± 0.07%). Sequences that were unclassified at
the phylum level accounted for 27.7 ± 5.5% of sequences.
Within Firmicutes, Clostridia was the dominant class,
accounting for 76% of OTUs from Firmicutes, with Rumi-
nococcaceae and Lachnospiraceae being the main families
(order, Clostridiales), representing 48 and 20% of se-
quences from Clostridia, respectively. Unclassified Clos-
tridia were common (24%), followed by smaller numbers
of Bacilli (2.9%).
Within Verrucomicrobia, Verrucomicrobiaceae was the
predominant (98%) family. Within that family, Akkerman-
sia and Persicirhabdus were the two identified genera, but
they only accounted for 9.9 and 0.2% of sequences from
Verrucomicrobia, respectively. The remaining members of
that family were unclassified at the genus level.
There were few differences between different time-
points and different rabbits at the phylum level. Rabbit 4
had a significantly higher relative abundance of Verruco-
microbia (12%) compared to the others (2.1-3.5%) (P =
0.03). No other differences between rabbits were evident
at the phylum level. There was a significant change in
the relative abundance of Proteobacteria over the four
timepoints (P = 0.02), with day 21 having a significant
higher relative abundance than the other three time
points. Otherwise, no significant differences between
timepoints were identified.
Dendrograms based on Jaccard and Yue & Clayton indi-
ces are presented in Figures 3 and 4. There were few dif-
ferences in microbial population structure. No effect of
sampling day was evident by unweighted unifrac (Table 1).
A significant difference was noted with parsimony test but
only between days 0 and 21 and using the Jaccard index.
Principle coordinate analysis results are presented in
Figures 5 and 6. Using AMOVA, there was no difference
between days using the Yue & Clayton index (P = 0.082),
Figure 1 Rarefaction curve demonstrating the change in number of operational taxon units (0.03 level) with increasing sequence
numbers in 6 rabbits over 4 different timepoints. Legend: rabbit number_sample day.
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0.011), with significant differences between days 0 and
21 (P = 0.002) and days 14 and 21 (P = 0.030).
Discussion
Rabbits enrolled in this study did not show any abnor-
mal clinical signs, hematological values, postmortem
evaluation, or physical changes of the hard feces
throughout the observed study period, thus suggesting
that the tested meloxicam dose can be considered safe
for clinical use.Figure 2 Distribution of the main phyla of the fecal microbiota of 6 h
6, 14 and 21) after meloxicam treatment.This study identified marked (but perhaps unsurpris-
ing) richness and diversity of the fecal microbiome that
is incomparable with culture-dependent studies, as an
average of over 2000 OTUs were identified. This and the
corresponding diversity indices highlight the complexity
of the rabbit fecal microbiota, even in rabbits housed
under controlled conditions with little or no variation in
diet and the need to use broad approaches such as this
to understand this environment.
The predominance of Firmicutes was not particularly
surprising, as this has been reported in other culture-ealthy adult rabbits (R1-R6) at four different time points (days 0,
Figure 3 Dendrogram depicting the Yue & Clayton measure of dissimilarity for six rabbits that underwent meloxicam treatment.
Legend: identifiers indicate Rabbit_sampling day.
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in other hindgut fermenters such as the horse [23,24]. It
was interesting to observe that Ruminococcaceae and
Lachnospiraceae were leading members of this phylum.
Those two families are receiving increasing attention in
various species as potentially key components of the
‘beneficial’ microbiota [23,25,26]. There is limited infor-
mation about these bacteria in rabbits, although they
were also reported to be dominant families in a study of
9-week old rabbits [27]. These may be critical compo-
nents of the rabbit microbiome and groups to study fur-
ther in terms of gut health and the loosely definedFigure 4 Dendrogram depicting fecal microbial community members
the traditional Jaccard index. Legend: identifiers indicate Rabbit_samplin‘intestinal dysbiosis’ that is often diagnosed in rabbits
with gastrointestinal disease [28].
While the predominance of Firmicutes was not unex-
pected, the utter dominance of this phylum was remark-
able. In studies of the fecal microbiome of most species,
while one phylum may be most common, there are typ-
ically multiple phyla with relative abundances greater
than 5% (or higher) [24,29-31]. Here, only one phylum
beyond Firmicutes accounted for greater than 1% of se-
quences. That was Verrucomicrobia, which accounted
for an average of 4.4% of sequences. Verrucomicrobia is
a relatively newly described and poorly characterizedhip of six rabbits that underwent meloxicam treatment based on
g day.
Table 1 Comparison of the microbial populations of six












Day0-Day6 0.48 0.83 0.16 0.56
Day0-Day14 0.71 0.80 0.56 0.57
Day0-Day21 0.17 0.32 0.02 0.58
Day6-Day14 1.00 0.80 0.94 0.57
Day6-Day21 0.73 0.89 0.93 0.93
Day14-Day 21 0.58 0.14 0.53 0.54
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dances in other species, including horses [24,32,33],
and has been shown to increase in abundance in mice
fed type 2 resistant starch [34], perhaps indicating an
important role in hindgut fermentation. Akkermansia
(a member of this phylum) has been shown to be decreased
in obese versus lean children and mice [35,36], to be asso-
ciated with improved glucose homeostasis in metformin
treated mice [37], to be associated with reversal of high fat
diet induced metabolic disorders in mice [36] and to be
reduced in humans with ulcerative colitis [38]. These
suggest that this phylum may play an important role in
gastrointestinal health in rabbits.
The number of sequences that were unclassified at the
phylum level was large, although within the range that has
been reported in other fecal microbiome studies and lower
than that reported in earlier cloning-based studies of theFigure 5 Three dimensional principle coordinate analysis, highlighted
circles-day14; x = day 21.rabbit cecal microbiota [10,39]. Even within sequences clas-
sified as members of the main phyla, Firmicutes and Verru-
comicrobia, there were large percentages of sequences that
were not identified to lower taxonomic orders. The re-
levance of these unclassified organisms is unclear. Un-
classified sequences are not necessarily unknown phyla.
Unclassified could indicate a sequence that does not have
any closely related sequences in the reference database, but
it could also indicate an inability of the analysis to assign a
sequence to known phyla (or lower taxonomic levels) be-
cause of similarities in sequences or because of limitations
in discriminatory power. Yet, unknown phyla could be
present, particularly because of the paucity of knowledge
regarding the fecal microbiota. The relevance of these in
health and disease is completely unknown but given the
high relative abundance, it must be assumed that this un-
classified component of the microbiota could be of im-
portance. This underscores our limited understanding of
this complex polymicrobial ecosystem and the need for
further study to define the microbiota and its individual
constituents.
When assessing the microbial composition of these
rabbits, there was surprisingly little clustering by indi-
vidual, as is evident from the dendrograms and PCoA
plot. With studies of other species, it is typically re-
ported that there is less intra-individual variation than
inter-individual variation [40,41], and if that was the
case here, clustering by animal would have been expected.
There are a few potential explanations. It is possible
that there was enough of an effect of treatment to alter
the microbiota of each rabbit, thereby disrupting intra-by treatment day. Legend: 5a:open box-day0; + = day6; closed
Figure 6 Three dimensional principle coordinate analysis, highlighted by rabbit. Legend: 5b: x: rabbit 1; open box rabbit 2, solid circle
rabbit 3; solid triangle rabbit 4; open triangle, rabbit 5; open circle, rabbit 6.
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in a consistent or strong enough manner to result in a
statistically significant effect of sampling day. Another
more likely explanation might be the nature of this
rabbit population, with similar genetics, housing and
diet that resulted in a very homogenous microbiota be-
tween individuals. Study of variation in the microbiota
of rabbits outside of a research colony would be en-
lightening. It is also possible that there is more inher-
ent variation in the rabbit microbiota, since a study of
rabbits reported similar intra- and inter-rabbit variation
[15]. However, that study also involved a homogenously
managed group of research rabbits so care must be taken
when interpreting the degree of inter- and intra- individual
variation from these studies.
Little impact of treatment was identified and there
were inconsistent results between different tests. Differ-
ences were noted between days 0 and 21 using parsi-
mony test and AMOVA, as well as days 14 and 21 using
AMOVA. However, these were only when analysis was
based on the Jaccard index. It is important to consider
differences between these indices. The Yue & Clayton
index is a measure of population dissimilarity based on
both microbial presence and abundance, while the Jac-
card index compares community membership without
assessment of the relative abundance of different mem-
bers of the community. Thus, differences in Jaccard but
not Yue & Clayton indices suggest that changes in the
community membership (addition or loss of members)
occurred, but that this may have mainly involved low
abundance members of community based on a lack of
difference when relative abundance is considered. Otherthan the potential long-term microbiota adjustment to a
new diet [42] the accumulated effect of meloxicam
should also be considered, and in the absence of clinical
or histologic abnormalities, only advanced molecular
testing methods had the sensitivity to detect subtle
changes in the rabbit’s GIT microbiota.
Limitations of the study must be considered. Since
there was no untreated control group raised in parallel
with these animals and they were all treated at the same
time, it is possible that there was some unidentified fac-
tor such as a subtle change in diet or stress that
accounted for the microbiota change. Additionally, it is
known that the fecal microbiome of laboratory raised
rabbits is different from rabbits raised under other con-
ditions (e.g. farms, households) [42-44]. As with similar
studies, there is always the question of how well the
fecal microbiome represents the microbiome in more
proximal sections of the gastrointestinal tract. That is an
inherent limitation given the inability to easily and non-
invasively obtain samples from different areas of the
gastrointestinal tract over time. It has been reported that
hard feces (which were studied here) are less representa-
tive of the cecal microbiota than soft feces [45] but con-
flicting data have also been reported [15,16]. These data
should therefore be interpreted as a description and com-
parison of the hard fecal microbiota. Optimal approaches
for studying the proximal intestinal tract in rabbits are not
known. The sample size may also have limited statistical
power; however, given the depth of data that are obtained
and the similar sample sizes that have been used in other
fecal microbiome studies, the sample size was deemed ad-
equate to identify significant changes in the microbiota.
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The fecal microbiome of the rabbit is a complex and di-
verse polymicrobial ecosystem, composed of a wide range
of both well-understood and completely unknown bac-
teria. While there were some noted differences over time,
there was no clear and consistent impact of meloxicam
treatment on the fecal microbiome. Given the importance
of the intestinal microbiome in health and disease, par-
ticularly amongst hindgut fermenting species such as the
rabbit, it is clear that there is inadequate understanding of
the ‘normal’ microbiota, how it varies within and between
rabbits, and how this complex polymicrobial ecosystem
influences (and is influenced by) disease, nutrition, man-
agement and myriad other factors.
In the absence of adverse clinical, histologic and signifi-
cant microbial changes observed in rabbits enrolled in this
study, it is suggested that alteration of the hard fecal micro-
biota is not a significant adverse reaction expected with
daily oral meloxicam administrated at the tested dose.
Availability of supporting data
The data set supporting the results of this article are
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